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Abstract 
Eukaryotic protein synthesis occurs in three phases: initiation, elongation and termination. 
The elongation phase is mediated by elongation factors. Elongation factors are divided into 
elongation factor 1 (eEF1) and elongation factor 2 (eEF2). Elongation factor 1 complex are 
proteins that mediates the extension of growing polypeptide chains by adding one amino acid 
residue at a time. The eEF-1 complex comprises of four subunits, eEF1α, eEF1β, eEF1γ and 
eEF1δ. The β-subunit of elongation factor 1 complex (eEF1) plays a central role in the 
elongation step of eukaryotic protein biosynthesis, which essentially involves interaction with 
the α-subunits (eEF1α) and γ-subunits (eEF1γ). To biophysically characterise heEF1β, three 
E. coli expression vector systems was constructed for recombinant expression of the full 
length (FL-heEF1β), amino terminus (NT-heEF1β) and the carboxyl terminus (CT-heEF1β) 
regions of the protein. NT-heEF1β was created from the FL-heEF1β by site-directed 
mutagenesis using mutagenic forward and reverse primers. The results suggest that heEF1β is 
predominantly alpha-helical and possesses an accessible hydrophobic cavity in the CT-
heEF1β. Both FL-heEF1β and NT-heEF1β forms dimers of size 62 kDa and 30 kDa, 
respectively, but the CT-heEF1β is monomeric. FL-heEF1β interacts with the N-terminus 
GST-like domain of heEF1γ (NT-heEF1γ) to form a 195 kDa complex, or a 230 kDa 
complex in the presence of oxidised glutathione. On the other hand, NT-heEF1β forms a 170 
kDa complex with NT-heEF1γ and a high molecular weight aggregate of size greater than 
670 kDa. This study affirms that the interaction between heEF1β and heEF1γ subunits occurs 
at the N-terminus regions of both proteins, also the N-terminus region of heEF1β is 
responsible for its dimerisation and the C-terminus region of heEF1β controls the formation 
of an ordered eEF1β-γ oligomer, a structure that may be essential in the elongation step of 
eukaryotic protein biosynthesis.  
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CHAPTER 1 
Introduction and literature review 
 
1.1 The translational elongation factor complex  
In the cell, proteins are required to achieve various tasks. In protein biosynthesis, biological cells 
generate new proteins. Protein synthesis in living cells occurs as a result of the translation of the 
genetic information encoded in the messenger RNA (mRNA) into a sequence of amino acids in 
the polypeptide chain. Eukaryotic protein biosynthesis involves three separate stages. They are 
initiation, elongation and termination (Chi et al., 1992). Eukaryotic elongation factors (eEF) play 
important roles in attaining precision during the translation process and are conserved throughout 
evolution (Olarewaju et al., 2004). In both prokaryotes and eukaryotes the small ribosome 
subunit aids the binding of the mRNA while the large ribosome subunit aids in peptide formation 
(Kozak, 1999). Translation process in prokaryotes is much faster than in eukaryotes. The 
elongation factors in prokaryotes are namely: EF-Tu and EF-Ts while in eukaryotes they are 
eukaryotic elongation factors 1 and 2 (eEF1 and eEF2). The eukaryotic elongation factor 1 
(eEF1) is further divided into four subunits namely eEF1α, eEF1β, eEF1γ and eEF1δ (Chi et al., 
1992; Le Sourd et al., 2006). 
 
1.2 Roles of elongator factor complex in protein biosynthesis 
Eukaryotic elongation factor 1 complex (eEF1) is made up of proteins responsible for extending 
a polypeptide chain through the addition of amino acid, one residue at a time. Eukaryotic 
elongation factor 1 is made up of two entities namely: G-protein (eEF1α) and nucleotide 
exchange factor (eEF1β, eEF1γ and eEF1δ). The G-protein plays an important role in selection 
of the amino acids and also the transferring of the amino acid to the acceptor site (A-site) of the 
ribosome thereby forming a complex (Le Sourd et al., 2006; Corbi et al., 2010). The nucleotide 
exchange factor (eEF1β, eEF1γ and eEF1δ) is required to regenerate eEF1α from the complex 
(eEF1α-GDP) to an active complex form (eEF1α-GTP) (Ito et al., 2004; Corbi et al., 2010). The 
aminoacyl-transferRNA (aa-tRNA) stimulates eEF1α to convert GTP to GDP by detaching 
GDP-bound eEF1α from the ribosome. Thereby leaving only the aminoacyl-tRNA (aa-tRNA) 
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attached to the acceptor site (Olarewaju et al., 2004). The eukaryotic elongation factor 1 gamma 
(eEF1γ) appears to be associated with β and δ subunits, and stimulates eEF1β in initiating the 
exchange of GDP to GTP on the subunit (Le Sourd et al., 2006) as shown in Figure 1. 
 
1.3   Human eukaryotic elongation factor one gamma  
The human eukaryotic elongation factor 1 gamma (heEF1γ) is about 47-52 kDa (Le Sourd et al., 
2006). It was initially characterised in invertebrate Artemia salina (Maessen et al., 1987; Gillen 
et al., 2008) and the human sequence has been published (Kumabe et al., 1992; Sanders et al., 
1992). It is made up of two domains connected by amino acids of approximately 60 residues, 
which are rich in lysine (Jeppesen et al., 2003). These two domains are (i) an amino terminal 
(NT) glutathione-S-transferase (GST) like domain and (ii) a protease-resistant carboxyl terminal 
(CT) domain. The GST-like domain is approximately 25 kDa and it is made up of α-helical and  
β-strands on the thioredoxin sub-domain (Vanwetswinkel et al., 2003b) (Figure 1.2a). The 
binding sites for eEF1β and eEF1δ are both on this domain. This domain has been shown to be 
phosphorylated at threonine 46 and threonine 223 (Le Sourd et al., 2006). The protease resistant 
carboxyl terminal contains a high number of aromatic amino acids and about 20% of all residues 
form antiparallel β-sheets enclosed by helices (Vanwetswinkel et al., 2003a). The available 
structural information on heEF1γ is the nuclear magnetic resonance spectroscopy (NMR) 
structure of the carboxyl terminal domain (PDB1D:1PBU) (Vanwetswinkel et al., 2003b) 
(Figure 1.2b).  
 
Although, heEF1γ appears dispensable for translation, its absence does not seem to affect the rate 
of translational elongation but it has been found to have other roles such as:  the GST domain of 
the heEF1γ has been shown to aid in detecting oxidative stress  (Jeppesen et al., 2003; Olarewaju 
et al., 2004). Over expression of heEF1γ occurs in several tumours and cancer, influencing 
tumour aggressiveness (Mimori et al., 1996; Mathur et al., 1998; Al-Maghrebi et al., 2005). The 
heEF1γ has affinity for membrane and cytoskeleton elements, and helps to anchor the other 
subunits of the eEF1 complex to the cytoskeleton (Kim et al., 2007). It is also a positive 
regulator of NF-kB signalling pathway (Seth et al., 2005; Liu et al., 2014). 
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Figure 1.1: Translation elongational complex: GTP forms complex with the eukaryotic elongation factor 
1A (eEF1A) and transports an aa-tRNA to the A site of the ribosome. GTP is broken down to GDP if 
codon-anticodon recognition takes place and eEF1A-GDP will be released. The eEF1A-GTP complex 
which is the active complex is regenerated by the exchange of GDP to GTP (Li et al., 2013). 
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Figure 1.2: Ribbon representation of the three dimensional structure of heEF1γ. (a) Superimposition of 
the homology model of the NT-GST like domain of heEF1γ (orange) into the modelling template (PDB 
ID: 4ECJ; GST from Pseudomonas aeruginosa in complex with glutathione). The homology model was 
generated through the Swiss Model structural prediction server (Guex and Peitsch, 1997) by Dr 
Ikechukwu Achilonu (b) Solution structure (PDB ID: 1PBU) of the C-terminus domain of the heEF1γ 
subunit (Vanwetswinkel et al., 2003a). 
a 
b 
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1.3.1 Ligandin functions of human eukaryotic elongation factor 1 gamma  
The GST-like NT domain of the heEF1γ has a reduced glutathione (GSH) binding site but cannot 
be compared to the other mammalian classes of GST (Achilonu et al., 2014) and this may be due 
to the heEF1γ having a G-site different from the typical GSTs and this is evident in the ability of 
heEF1γ to bind oxidised glutathione (GSSG) more firmly than reduced glutathione (GSH) 
(Tshabalala et al., 2016). The preference of GSSG over GSH could be important in certain 
diseases such as multiple sclerosis, Parkinson’s, Alzheimer’s and tumorigenesis, because studies 
have shown that decreased molar ratio of GSH/GSSG is related to oxidative stress seen in these 
diseases (Jones et al., 2000). Physiologically GSH (about 10 mM) is more abundant than GSSG 
(0.1 mM). This could be the reason why heEF1γ is relatively high in cancer cells compared to 
other eEF1 subunits (Ernst et al., 1978).  
 
1.4 The human eukaryotic elongation factor 1 beta   
Human eukaryotic elongation factor one beta (heEF1β) has 225 amino acids and its monomeric 
weight is about 26-30 kDa  (Pérez et al., 1998). The heEF1β has two domains which are: amino 
terminal (NT) domain and the carboxyl terminal (CT) domain connected to each other by a 
section of acidic amino acids residues (van Damme et al., 1990). The NT domain is highly 
homologous with a GST-like CT domain, while the CT domain of the heEF1β contains about 
100 amino acids and has the nucleotide exchange activity. The amino acid sequence of the 
rabbit’s eEF1 has 98% homology with human eEF1 except for isoleucine 72, glycine 43, and 
arginine 78 present in the rabbit being replaced while alanine replaced valine 156 (Chen and 
Traugh, 1995). Studies have shown that both eEF1β and eEF1δ are homologous because they 
contain nucleotide exchange activity and they share over 81% sequence similarity from the acid-
rich region downstream (van Damme et al., 1990).  
The heEF1β catalyses the GDP/GTP exchange activity on eEF1α and is also very essential in the 
regeneration of eEF1α (Chen and Traugh, 1995) which completes one elongation cycle. It also 
plays an important part in the oxidative stress response pathway (Olarewaju et al., 2004). The 
eukaryotic elongation factor 1 beta (eEF1β) has been shown to be a marker for detecting cellular 
senescence (Byun et al., 2009). It is also important in the formation of high molecular weight 
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eEF1 complexes by providing binding sites for both α and γ subunits. (van Damme et al., 1990; 
van Damme et al., 1992). 
 
1.5 Protein-protein interaction  
Specific complimentary recognition of two or more peptides to form a stable structure is termed 
protein-protein interactions (Werther and Seitz, 2008). Protein-protein interactions (PPIs) lead to 
the formation of dimeric or multimeric proteins. Multimeric proteins are found in the cytosol, 
cell membrane and cell organelles (Hardy et al., 1988). Many proteins self-associate to form 
homodimers. Homodimerisation can occur between monomers in solution with or without 
intervention from promoters (Nussinov et al., 1998). Most homodimers exist in their dimeric 
state and it is very difficult to separate them without denaturing their individual monomeric 
structures. PPIs are usually complex and their stability is attributed to and regulated by some 
environmental conditions such as changes in pH, temperature, ionic strength, and covalent 
modifications such as phosphorylation (Markus and Benezra, 1999). PPIs can be classified based 
on stability and mechanism of the protein-protein complex.  
 
PPIs occur between hetero-oligomer (non-identical) and homo-oligomer (identical) peptide 
chains. Homologous protein oligomers can be arranged in an heterologous or isologous manner 
with structural symmetry (Goodsell and Olson, 2000). Heterologous interaction involves the use 
of different interfaces which can lead to unending aggregation because it does not have a closed 
symmetry, while isologous interaction uses the same surface on both monomers (Nooren and 
Thornton, 2003).  
 
Obligate PPIs involves the use of promoters that are unstable structures when they are on their 
own and an example of such promoters is Arc repressor dimer which is very essential for DNA 
binding (Jones and Thornton, 1996). Non-obligate PPIs involves the use of promoters that can 
exist on their own and their components are stable independently. Also each interacting pair of 
proteins has their own unique complex interface. Examples of non-obligate PPIs include 
HYHEL-5 with lysozyme which is an  antibody-protein complex and enzyme-inhibitor complex 
trypsin found in bitter gourd (Jones and Thornton, 1996; Archakov et al., 2003).  
7 
 
PPIs are classified as permanent or transient based on their life span and nature of interaction. 
Permanent complexes are stable with protein-protein interfaces that are closely packed together 
and have fewer intersubunit hydrogen bonds (Jones and Thornton, 1996). Their surface 
properties are very close to that of the protein core because they are extension of the protein 
folding. Permanent complexes exhibit the highest complementarity while transient or temporary 
complexes have the lowest complementarity (Jones and Thornton, 1996; Tsai et al., 1997). Non-
obligate interactions can be permanent or transient while obligate interactions are permanent 
(Nooren and Thornton, 2003). 
In multimeric proteins, PPIs are essential for normal functioning of cells (Teichmann, 2002) 
which includes: transportation of cholesterol and lipids among certain cells in the body which is 
achieved by the interaction between the plasma protein apolipoprotein E and low density 
lipoprotein receptors (Mahley, 1988), catalysing metabolic reactions and changing specificity of 
the protein (Peng et al., 2016). PPIs form the basis of the quaternary structure (Jones and 
Thornton, 1995) and changes in the quaternary state of the protein can lead to a biological 
function or activity (Nooren and Thornton, 2003). PPIs are important biological regulators as 
seen in during the association of polypeptides with each other or with nucleic acids and 
phospholipids (Pawson and Nash, 2003). They are also very essential in designing drugs, 
optimisation of drug therapies already in use (Archakov et al., 2003; Wendt, 2012) as well as 
cancer therapeutic strategy (Peng et al., 2016). PPIs facilitate biochemical functions such as 
enzyme cooperativity and signal transduction (Jones and Thornton, 1995; Jones and Thornton, 
1996). In order to understand the dynamics and stability of proteins, PPIs in cells are very 
essential in discovering the structure and functions of many unknown proteins (Figeys, 2002). 
Some novel proteins can be assessed by describing their localisation in the cell (Teichmann, 
2002) and certain functions could be allotted to the protein based on the known functions of their 
interacting partners (Schwikowski et al., 2000). PPIs can be driven by polar interactions 
(hydrogen bonds and van der waals’), electrostatic interactions (salt bridges) and hydrophobicity 
among others. 
 
Hydrophobicity is one of the major driving forces in the stabilisation of protein folding and in 
PPIs. Hydrophobic interactions describes  the free energy gained when non-polar residues of 
proteins interact in polar environment (Kauzmann, 1959), and can be known as solvent entropy. 
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Hydrophobic effect on protein structure was first identified by Kauzmann (1959) and he 
proposed that in aqueous environment, proteins tend to bury the non-polar amino acid residues 
while orienting those with polar or charged side chains to interact with the solvent molecules. 
Entropy lost by protein molecules while forming complexes was compensated by the entropy 
gained by water as a result of the accessible protein surface area (Chothia and Janin, 1975). This 
process is entropically driven at room temperature because the addition of non-polar molecules 
to water disrupts the hydrogen bonded structure of water hence the water molecules arrange 
themselves so that they can have greater contacts with themselves and lesser contacts with the 
non-polar substance  (Geiger et al., 1979; Stillinger, 1980). Averaged values of the contact 
surface hydrophobicity represent the mean hydrophobicity value of the protein core and its 
surface (Janin et al., 1988). Hydrophobic areas in the contact interface are arranged as patches 
and the proteins associate through the hydrophobic patches on their surfaces (Jones and 
Thornton, 1996). The number and size of these patches vary. Hydrophobic interactions are 
greater in permanent complexes and lesser in temporary complexes. Some of the examples of 
PPIs driven by hydrophobicity are dimeric porcine insulin, αβ dimer of horse oxy-haemoglobin 
and bovine trypsin-pancreatic inhibitor complex (Chothia and Janin, 1975).  
 
PPIs can also be driven by hydrogen bonds. Hydrogen bonding is a non-covalent interaction 
which involves the sharing of hydrogen atom between hydrogen bond donor group such as 
hydroxyl group (-OH) or amino group (NH2) and hydrogen bond acceptor groups such as oxygen 
atom or nitrogen atom which are the peptide backbone groups and the polar amino side chains in 
proteins (Sticke et al., 1992). Hydrogen bond is an intrinsic component of PPI and has been 
suggested to bring about specificity in PPI (Fersht, 1987). Backbone hydrogen bonds are mainly 
local whereas at the domain interfaces most hydrogen bond contributions are due to polar 
residues since these contacts are mostly non-local. The strength of the hydrogen bond will 
depend on the relative angles and distances. Hydrogen bonds involving the main chain atoms 
determine the stability of  the protein’s secondary structures (Creighton, 1991). In α-helix the 
backbone is tightly wound around a central axis with a full turn for every 3.6 amino acid 
residues. For every amino acid residue forming the helix except for the end residues, a hydrogen 
bond is formed between the hydrogen attached to the nitrogen of the backbone and the carbonyl 
oxygen of the amino acid residue four positions along the chain whereas in β-pleated sheets 
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hydrogen bonding occurs between the nitrogen atoms and carbonyl oxygen atoms of the 
backbone. Intra-molecular hydrogen bonds form to replace the fluctuating intra and inter 
molecular bonds that form in the unfolded protein so that the native state is favoured 
enthalpically in the folded conformations. Though hydrogen bonds are not the main folding force 
they are also important in maintaining protein stability (Dill, 1990). Hydrogen bonds are 
observed at protein interfaces at an average of about 10 bonds per interface or one bond per each 
100-200 Å
2
 (Jones and Thornton, 1996). Examples of PPIs driven by hydrogen bonds are human 
immunodeficiency virus (HIV) protease (Navia et al., 1989) and subtilisin inhibitor homodimer 
(Mitsui et al., 1979).  
Salt bridges also known as specific charge contact are electrostatic interactions formed between  
acidic amino acids which are negatively charged such as aspartic or glutamic acid and basic 
amino acids that are positively charged such as arginine, lysine and histidine. Based on the 
geometry, location in the protein, whether they are hydrogen bonded or not, the energy 
contribution of salt bridges varies between 5-15 kcal mol
-1
 (20-60 kJ mol
-1
)
 
per ion pair.
 
Due to 
the high amount of energy required for the transfer of charged ions from a polar to a non-polar 
environment, the amount of ion pairs at the dimer interfaces and domains of the proteins are low. 
This energy is known as Born energy and it is about 80 kJ mol
-1
 (Dill, 1990). Salt bridges are 
thereby responsible for correct packing and binding specificities in protein interiors, domains and 
dimer interfaces. Salt bridges are usually stabilising although they stabilise proteins only under 
favourable packing conditions in a non-polar environment (Kumar and Nussinov, 1999). 
Association of proteins is mainly due to complementarity in structure and also the co-operation 
of some weak forces such as van der waals’ interaction. Although van der waals’ interactions are 
less energetic, they are more numerous than hydrogen bonds. The overall contribution of van der 
waals’ in PPIs is very small, but has been found to be essential in determining which protein 
recognise another protein (Chothia and Janin, 1975).  
Proteins forming PPI must maintain a stable conformational surface to enable recognition and 
binding interaction. Most proteins are specific in their choice of binding partners and examples 
include hormone-receptor and antibody-antigen complex, while some are multispecific having 
more than one binding partners examples include regulatory pathways such as RhoGAP which is 
an intracellular cell signalling network (Nooren and Thornton, 2003). Complementarity of shape 
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and chemistry which determines the free energy of binding brings about specificity. Non-native 
PPI partners will not form PPI. The propensity of PPI is an index of native and active protein 
performing a biological function. 
 
1.6 Protein-protein interaction between the subunits of eEF1 complex 
Complex formation between the four subunits of eEF1 increases the activity of the molecule 
(Motorin et al., 1991). The CT-domain of eEF1α interacts with the CT-domain of eEF1β and this 
interaction is of great importance because eEF1β triggers the exchange of GDP to GTP and 
protects eEF1α against tryptic cleavage (van Damme et al., 1992). The CT-domain of eEF1δ 
interacts with the CT-domain of eEF1α (Janssen et al., 1994). Furthermore eEF1δ interacts with 
eEF1γ and the complex eEF1βγ but not with eEF1β alone, this could be due to the  
conformational changes in both secondary and tertiary structure of the complex, thereby creating 
a binding site for eEF1δ (Janssen et al., 1994). Recombinant eEF1βγδ stimulate the activity of 
EF1α by up to 10-fold, indicating that it is a functional complex that produces a greater level of 
stimulation than both eEF1β and eEF1βγ (Sheu and Traugh, 1997). In order to acquire more 
detailed information on how the complexes formed by the subunits of eEF1 are structurally 
and functionally related to each other as well as the role of eEF1β in the complex eEF1αβγδ 
during protein synthesis, there is need for a more advanced study of the β-γ subunits interactions. 
Detailed analysis is required to assess comprehensively how proteins interact and exchange 
information. 
The β and γ subunits of eEF1 complex form a single functional unit, which can only be 
dissociated with the use of denaturants (Chen and Traugh, 1995). The β subunit binds to the NT-
domain of the γ subunit (van Damme et al., 1990).  Although, studies have shown that the 
nucleotide exchange activity resides in the β subunit and not γ subunit (Janssen and Moller, 
1988), the rate of GDP exchange increased in αβγ complex when compared to αβ subunit (van 
Damme et al., 1990). The amino terminal of the complex eEF1βγ is the binding site for eEF1δ 
subunit (Janssen et al., 1994) since eEF1δ subunit has never been reported to interact with eEF1β 
alone. The level of expression of eEF1βγ increased in certain tumour cells (Veremieva et al., 
2014) indicating independent effect of this complex in some tumours and hence the importance 
for extensive study of this protein-protein interaction.  
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1.7 Aim and objectives 
The β-subunit of elongation factor 1 complex (eEF1) plays an essential role in the elongation 
step in eukaryotic protein biosynthesis, which essentially involves interaction with the α- and γ-
subunits. The functional rationale for these complexes (EF1βγ and EF1βα) are not fully 
understood, hence the need for further studies on the protein-protein interactions. This work was 
aimed to biophysically characterise heEF1β by constructing three E. coli expression vector 
systems for recombinant expression of the full length (FL-heEF1β), N-terminus (NT-heEF1β) 
and the C-terminus (CT-heEF1β) regions of the protein and to qualitatively assess its interaction 
with heEF1γ in the presence oxidised glutathione ligand (GSSG). These aims are to be achieved 
with the following objectives: 
 Confirm the identity of the gene containing FL-heEF1β by sequencing the plasmid. 
 Create NT-heEF1β fragment from FL-heEF1β using site directed mutagenesis. 
 Express and purify FL-heEF1β, NT-heEF1β and CT-heEF1β to homogeneity. 
 Secondary characterisation of FL-heEF1β, NT-heEF1β and CT-heEF1β using far-UV 
circular dichroism (CD). 
 To assess the hydrophobic binding pockets of heEF1β using extrinsic-ANS binding 
fluorescence assay. 
 Quaternary structure characterisation of FL-heEF1β, NT-heEF1β and CT-heEF1β using 
size exclusion high pressure/performance liquid chromatography (SE-HPLC). 
 Functional characterisation by protein-protein interactions of FL-heEF1β, NT-heEF1β 
and CT-heEF1β with heEF1γ using size exclusion high performance liquid 
chromatography (SE-HPLC) in the presence and absence of oxidised glutathione ligands 
(GSSG). 
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CHAPTER 2 
Materials and methods 
 
2.1 Materials 
The synthesised codon harmonised gene encoding full length heEF1β which were cloned using 
NdeI and Bam H1 restriction sites into pET-28a plasmid to create pTFL-heEF1β were kindly 
provided by Dr Ikechukwu Achilonu. All other reagents used were of analytical grade.  
Table 1: Non-standard materials and suppliers. These are some of the chemicals and materials 
used during this research study and companies where they were purchased. 
Materials Source Location 
Mutagenesis primers Inqaba Biotech Pretoria, South Africa 
GeneJet
TM
 plasmid miniprep kit Fermentas Ontario, Canada 
Quikchange II XL Site directed mutagenesis kit Stratagene La Jolla, Ca, USA 
SDS Molecular weight markers Fermentas Ontario, Canada 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Sigma-Aldrich St. Louis, MO, USA 
Dithiothreitol (DTT) Melford Laboratories Suffolk, UK 
Coomassie Brilliant Blue-G250 Sigma-Aldrich St Louis, MO,USA 
BL21 codon plus competent cells New England Biolabs Ontario, Canada 
IMAC columns (nickel and cobalt) GE Healthcare Buckinghamshire, UK 
Antibiotics (ampicilin and chloramphenicol) Roche Diagnostics Manheim, Germany 
Yarra™ 3u SEC-2000, LC Column  Phenomenex Torrence, CA, USA 
 
2.2 Methods 
2.2.1 Construction of expression vectors 
The gene sequence encoding heEF1β open reading frame (ORF) with the accession number 
CAG33106.1 was retrieved from GenBank and was codon harmonised to enable expression 
Escherichia coli (E.coli). Codon harmonisation is an algorithm developed from the relationship 
between the secondary protein structure and codon usage frequencies in an heterologous 
expression in order to improve expression (Angov et al., 2008). The harmonised sequence 
encoding FL-heEF1β and CT-heEF1β were synthesised and cloned into pET-28a and pET-11a 
vector by GenScript Corporation (NJ, USA) for the expression of FL-heEF1β and CT-heEF1β 
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respectively. Both the CT-heEF1β and FL-heEF1β sequences have NT-hexahistidine tag 
incorporated into them to enable purification using immobilised metal affinity chromatography. 
The synthesized gene was cloned using the NdeI and BamHI restriction sites into the plasmids to 
create pTFL-heEF1β (Achilonu et al., 2014). Six proteins construct which are: FL-heEF1γ, NT-
heEF1γ, CT-heEF1γ, FL-heEF1β, NT-heEF1β and CT-heEF1β were used in this study (Figure 
2.1). The FL-heEF1γ, NT-heEF1γ and CT-heEF1γ protein plasmids were provided from 
previous research (Achilonu et al., 2014).  
2.2.2 Plasmid extraction and sequencing 
The pET-28a is a bacterial expression vector with T7 lac promoter, thrombin cleavage site and   
an N-terminal histagged sequence. The histag allows for effective detection and purification of 
the protein. The pET-28a vector encodes a gene for kanamycin resistance by while the pET-11a 
plasmid encodes a gene for ampicillin resistance by NdeI/BamHI, thus selecting only the cells 
containing the plasmids. The plasmids (pTFL-heEF1β) were extracted from the cells using 
GeneJet
TM
 plasmid miniprep kit based on alkaline lysis (Bimboim and Doly, 1979) in accordance 
with the protocol detailed as follows: 1 ml cell culture was centrifuged at 27000×g twice, to 
harvest the cells after which 250 μl of resuspension solution was added to the cells to maintain 
optimal pH and chelate divalent cations because it contains EDTA which inhibit enzymes from 
cleaving the plasmid DNA. A pipette was used to resuspend the cells by gentle aspiration. The 
cells were then lysed under alkaline conditions by the adding 250 μl of lysis solution containing 
SDS (sodium dodecylsulfate) and NaOH until the solution becomes viscous and slightly clear. 
Thereafter, 350 μl of the neutralisation solution containing sodium acetate was added and mixed 
thoroughly by inverting the tube four to six times to neutralise the reaction and to precipitate out 
the proteins and larger genomic DNA. The cell solution was centrifuged at 27000×g for 5 min to 
pellet cell debris and chromosomal DNA, after which the supernatant was   decanted into a 
GeneJet spin column which contains a silica-based membrane that binds the plasmid DNA and 
then centrifuged at 27000×g for 1 min, the column was placed back in the same collection tube 
after the flow-through was discarded. The plasmid DNA bound to the column was washed twice 
with 500 μl washing solution centrifuged at 27000×g for 1 min and the column placed back in 
the same collection tube after discarding the flow through. The plasmid solution was centrifuged 
again at 27000×g for 1 min to remove residual wash solution and ethanol in the DNA plasmid. 
The GeneJet spin column was then transferred into a fresh Eppendorf tube. The plasmid DNA 
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was eluted with elution buffer and then incubated at room temperature for 2 min. The plasmid 
DNA solution was then centrifuged at 27000×g for 2 min and stored at ˗20ºC. The purified 
plasmid was sent to Inqaba Biotech (Pretoria, South-Africa) for sequencing. The chromatogram 
received from Inqaba Biotech contained gene sequence which was translated using the online 
server ExPASy translate (Artimo et al., 2012). The translated amino acid sequences (Figure 2.2) 
were then compared with the sequence in the database using the basic alignment search tool 
(BLAST) and to confirm the proteins identity (Altschul et al., 1990).  
 
2.2.3 Site Directed Mutagenesis 
Site directed mutagenesis involves the extensive analysis of gene structure and function (Shenoy 
and Visweswariah, 2003). The amino terminus (NT) fragment of both proteins heEF1β and 
heEF1γ were created out of their respective full length (FL-heEF1β and FL-heEF1γ) by site 
directed mutagenesis (Figure 2.3) using mutagenic primers (reverse and forward). For heEF1β, a 
stop codon was encoded at Lys 79 (AAA→TAA) which is a single nucleotide change. The 
length of plasmid and each protein (FL-heEF1β and FL-heEF1γ) is approximately 6000 bases 
and the time of cycle is about 3 h. The reaction mixtures in a total volume of 50 μl consisted of:  
 
I- HeEF1β: 2.5 μl FL- heEF1β-pET 28 plasmid, 1.5 μl (125 ng) forward primer, 1.5 μl 
(125 ng) reverse primer, 5.0 μl reaction buffer, 1.0 μl dNTP mix, 1.5 μl Quiksolution 
reagent and 37 μl sterile MilliQ H20.  
II- HeEF1γ: 1.0 μl FL- heEF1γ-pET 11 plasmid, 2.0 μl (125 ng)  reverse primer, 2.0 μl 
(125 ng)  forward primer, 5 μl Reaction buffer, 1.0 μl  dNTP mix, 1.5 μl Quiksolution 
reagent and 37.5 μl sterile MilliQ H20. 
 
The Biorad Mycycler
TM
 was used and the cycling parameters used were as follows: two 
amplification cycles of 2 min at 95ºC as the starting temperature followed by 18 cycles 
consisting of denaturation step at 95ºC for 20 sec, an annealing step at 60ºC for 10 sec which is a 
temperature suitable for the primers, then an extension step at 68ºC for 220 min. Finally one 
cycle of 68ºC for 5 sec, this is the holding temperature. 2 μl of Dpn I was added to the reaction 
mixture and incubated at 37ºC for 5 min to cleave methylated DNA (Braman et al., 1996). The 
reaction products were then used to transform E.coli JM109 competent cells as follows:
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Figure 2.1: Schematic representation of the constructs used in this study.  For the heEF1γ protein three 
constructs used are: CT- heEF1γ and NT-heEF1γ were used. NT-heEF1γ was created through site 
directed mutagenesis by encoding a stop codon between the NT-domain and CT-domain of FL-heEF1γ. 
While for the heEF1β protein the constructs were: FL-heEF1β, CT-heEF1β and NT-heEF1β. NT-heEF1β 
created by site directed mutagenesis which involved encoding a stop codon on Lys 79 of the FL-heEF1β. 
          
 
 
 
MGSSHHHHHHSSGLVPRGSHMGFGDLKSPAGLQVLNDYLADKS
YIEGYVPSQADVAVFEAVSSPPPADLCHALRWYNHIKSYEKEK
ASLPGVKKALGKYGPADVEDTTGSGATDSKDDDDIDLFGSDDE
EESEEAKRLREERLAQYESKKAKKPALVAKSSILLDVKPWDDE
TDMAKLEECVRSIQADGLVWGSSKLVPVGYGIKKLQIQCVVED
DKVGTDMLEEQITAFEDYVQSMDVAAFNKI 
 
Figure 2.2: Amino acid composition of FL-heEF1β.  The  NT-domain is in red with an hexahistidine tag 
and the underlined sequence represents the CT-GST like region of the NT-domain. The CT- heEF1β is 
indicated in black. 
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2 μl of the JM109 cells was thawed on ice, 1 μl of the NT-heEF1β mixture was added to it and 
then left on ice for 30 min to stabilise the lipid membranes of the cells. The cells were heat-
shocked for 45 sec at 42ºC on a heating block to alter the state of the fluid membrane by 
increasing its permeability and allowing the DNA to enter the cell. It was immediately put back 
on ice to cool down for 5 min. Thereafter, 750 μl of SOC media [2% (w/v) tryptone, 0.5% (w/v) 
yeast extract, 250 mM KCl, 2 M MgCl2, 1 M glucose] was added to the transformed cells to 
provide nutrients and allow the cells to grow. The cells were then incubated at 37ºC for 1 h with 
shaking at 230 rpm and then plated onto lysogeny broth (LB) agar plates [1% (w/v) tryptone, 
1.5% (w/v) agar, 0.5% (w/v) yeast extract, 1% (w/v) NaCl] containing 30 μg/ml kanamycin 
sulfate and subsequently incubated overnight at 37ºC. Transformants were selected at random 
and the plasmid DNA was extracted from the JM109 cells using the molecular biology 
Thermoscientific kit protocol as described above (section 2.2.2).  
 
2.2.4 Transformation and over expression 
Recombinant proteins (FL-heEF1β, CT-heEF1β, NT-heEF1β, CT-heEF1γ and NT-heEF1γ) were 
used to transform E. coli BL21 Codon Plus (Agilent) expression cells. The competent cells were 
transformed using the method described by Chung and colleagues (1989). BL21 codon plus 
competent cells were thawed on ice for 5-10 min after which 2 μl of pT-heEF1β plasmid was 
added. The reaction mixture was then incubated on ice for 30 min, heat shocked at 42ºC for 
45 secs on a heating block and immediately transferred on ice for 5 min. The cells were grown 
by adding 750 μl of SOC media [2% (w/v) tryptone, 0.5% (w/v) yeast extract, 250 mM KCl, 2 M 
MgCl2, 1M glucose] to the reaction mixture followed by incubation at 37ºC using a shaker 
incubator at 250 rpm agitation for 1 h. The cells were then placed on LB- agar plates [1% (w/v) 
tryptone, 1.5% (w/v) agar, 0.5% (w/v) yeast extract, 1% (w/v) NaCl] containing the antibiotics 
100 μg.mL-1 kanamycin and 30 μg.mL-1 chloramphenicol for heEF1β and 100 μg.mL-1 
ampicillin and 30 μg.mL-1 chloramphenicol for heEF1γ and then incubated at 37ºC overnight (~ 
16 h). 
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Figure 2.3: Site directed mutagenesis using mutagenic primers (reverse and forward). (a) Schematic 
representation of site directed mutagenesis used to create NT- heEF1γ from FL- heEF1γ which is an NT-
GST-like domain  (b) Schematic representation of site directed mutagenesis used to create NT- heEF1β 
from FL- heEF1β by encoding a stop codon at Lys79 (AAA→TAA single nucleotide change).  
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The transformed cells were then picked from the colonies observed on the LB-agar plates and 
added to freshly prepared sterile 2×YT media [1% (w/v) yeast extract, 1.6% (w/v) tryptone, 0.5% 
(w/v) NaCl] supplemented with 100 μg.mL-1 kanamycin and 30 μg.mL-1 chloramphenicol and 
incubated at 37ºC overnight with 250 rpm agitation. A 50-fold dilution was used to inoculate 
fresh sterile 2×YT media supplemented with 100 μg.mL-1 kanamycin and 30 μg.mL-1 
chloramphenicol, 10 µl antifoam 204 was added and then incubated at 37ºC, 250 rpm agitation 
till an OD600 ~0.5 was reached. Cell culture was then chilled on ice for 10 min. Cold induction 
was done using 0.5 mM IPTG for expression of the proteins (FL-heEF1β, CT-heEF1β, NT-
heEF1β, CT-heEF1γ and NT-heEF1γ). The cells were grown for a further 6 h, incubated at 30ºC 
with shaking at 250 rpm to achieve optimum protein expression. Aliquots of 1000 µl cell culture  
collected at 0, 2 h, 4 h, 6 h and 16 h post-induction was analysed using tricine-SDS PAGE. Cells 
were pelleted by centrifugation at 5000×g for 25 min. Harvested cells were resuspended with 
buffer A [50 mM Tris-HCl, 0.02% (w/v) NaN3, 10% (v/v) glycerol, 1 M NaCl, 40 mM imidazole 
pH 7.4] and then stored at -20ºC. 
 
2.2.5 Purification 
2.2.5.1 Immobilised metal affinity chromatography 
The frozen lysed cell suspensions were thawed at 37°C and then thawed on ice by sonication for 
five cycles of 30 sec bursts, using a power output of 12 with a Sonicator Ultrasonic Processor 
(Misonix Incorporated). The lysed cells were then centrifuged at 25000×g for 30 min at 4°C to 
pellet the insoluble fraction. Decanted supernatant (soluble fraction) was subsequently loaded to 
a 5 ml nickel resin column for FL-heEF1β, CT-heEF1β, NT-heEF1β and CT-heEF1γ and cobalt 
resin for NT-heEF1γ which has been pre-equilibrated with buffer A using the ÄKTA FPLC (fast 
protein liquid chromatography) purification system (GE Healthcare) coupled to a computer with 
prime view 1.0 software. The column was then washed with 10 column volumes of the buffer A 
followed by 10 column volumes of buffer B [50 mM Tris-HCl, 0.02% (w/v) NaN3, 10% (v/v) 
glycerol, 1 M NaCl, 40 mM imidazole, 1% (v/v) Triton X-100, pH 7.4] and finally washed with 
10 column volumes buffer A to remove excess Triton X-100. The bound proteins were eluted off 
the column using the eluting buffer C [50 mM Tris-HCl, 0.02% (w/v) NaN3, 10% (v/v) glycerol, 
1 M NaCl, 250 mM imidazole pH 7.4]. Eluted proteins were collected in fractions and tested for 
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presence of protein using Bradford reagent. Tricine SDS-PAGE was used analyse the purity of 
the protein and the concentration assessed by Beer-Lamberts law.  
 
2.2.5.2 Ion exchange chromatography 
Ion exchange chromatography involves the interaction between the charged molecules in the 
mobile phase and the oppositely charged groups attached to the stationary phase. Diethyl 
aminoethyl are positively charged ion exchange matrices used as anion exchangers because they 
bind to proteins that have an overall negative charge. Proteins are released from the resin by 
increasing the salt concentration of the buffer or changing the pH of the solution. IMAC purified 
fractions of FL-heEF1β and NT-heEF1β proteins were pulled together and dialysed (16 h, 4°C) 
against buffer D [50 mM Tris-HCl, 0.02% (w/v) NaN3, 10% (v/v) glycerol, 1 mM EDTA, 1 mM 
EGTA, 0.1 mM TCEP pH 7.4] and then further purified by loading onto a 20 ml DEAE column 
that is connected to an Äkta Prime FPLC system, which has been pre-equilibrated with buffer D. 
The proteins were eluted using the DEAE elution buffer E [50 mM Tris-HCl, 0.02% (w/v) NaN3, 
10% (v/v) glycerol, 1 mM EDTA, 1 mM EGTA, 0.1 mM TCEP, 300 mM NaCl, pH 7.4]. Eluted 
protein fractions were collected and assessed for purity using SDS-PAGE gel. 
 
2.2.5.3 Glutathione-Agarose affinity chromatography 
Glutathione (GSH)-Agarose affinity chromatography is used for non-denaturing and highly 
selective purification of proteins containing glutathione such as glutathione peroxidase and GST. 
Due to the GST-like amino terminal domain of heEF1γ, both NT-heEF1γ and FL-heEF1γ have 
high affinity for glutathione. The agarose beads were washed thoroughly with 10 column 
volumes of buffer F [50 mM Tris-HCl, 0.02% (w/v) NaN3, 1 M NaCl, pH 7.4] to equilibrate the 
column. The IMAC purified fractions NT-heEF1γ protein collected were pulled together and 
dialysed (16 h, 4°C) against buffer G [50 mM Tris-HCl, 0.02% (w/v) NaN3, 1M  NaCl, 2 mM 
DTT pH 7.4] to remove the excess imidazole. The dialysed proteins were then passed through 
the GSH-agarose column and then washed with 10 column volumes of buffer H [50 mM Tris-
HCl, 0.02% (w/v) NaN3, 1M  NaCl, 2 mM DTT, 1% (v/v) Triton x-100 pH 7.4] followed by 10 
column volumes of buffer F to remove excess Triton x-100 detergent. Bound proteins were 
eluted with buffer I [10 mM Glycine-NaOH, 0.02% (w/v) NaN3 pH 10]. Eluted protein fractions 
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were collected and their pH immediately adjusted to ~7.5 by adding 1 M Tris-HCl pH 7.4 at 25% 
(v/v). The purity of the proteins collected was assessed using tricine SDS-PAGE. 
 
2.2.6 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a technique used to 
assess the expression and purity of the protein. Both glycine SDS-PAGE and tricine SDS-PAGE 
could be used based on the size of the protein, but in this study both were used based on the 
availability in the laboratory.  
 
2.2.6.1 Tricine-based sodium dodecyl sulfate polyacrylamide gel electrophoresis 
 
The size, solubility and purity analysis of the proteins were assessed using the tricine SDS-
PAGE according to the method described by Herman Schӓgger. The principle of this technique 
is similar to SDS-PAGE except that tricine is used instead of glycine as the trailing ion and it is 
mainly used in the separation of small proteins and peptides smaller than 30 kDa (Schägger, 
2006). Protein samples were prepared in 2:1 dilution with loading buffer [0.5 mM Tris-HCl, 20% 
(v/v) glycerol, 10% (w/v) SDS, 100 mM β-mercapto ethanol, 0.05% bromophenol blue, pH 6.8] 
and boiled at 100°C for 5 min to ensure complete denaturation before loading onto gel. The 
separating gel consists of 0.6% (w/v) acrylamide/bisacrylamide, 1% (w/v) gel buffer (3×), 
0.3%  (v/v) glycerol, 1.5% (w/v) ammonium persulfate, 0.005% (w/v) TEMED and the stacking 
gel consists of 0.1% (w/v) acrylamide/bisacrylamide, 0.3% gel buffer (3×), 0.009% (w/v) 
ammonium persulfate, 0.005% (w/v) TEMED. The anode buffer used consist of 1 M Tris-HCl, 
pH 8.9 and the cathode buffer consist of 1 M Tris, 1 M Tricine, 1% SDS, pH 8.25. 20 μl of the 
protein sample was loaded into the SDS-PAGE wells and electrophoresed at 160 volts for 90 min 
using a PowerPac
TM
 Basic Bio-Rad electrophoresis system. The molecular weight marker used 
contained a mixture of seven proteins: lysozyme (14.4 kDa), β-lactoglobulin (18.4 kDa), 
restriction endonuclease Bsp98I (25 kDa), lactate dehydrogenase (35 kDa), ovalbumin (45 kDa), 
bovine serum albumin (66.2 kDa), and β-galactosidase (116 kDa). The gels were stained in a 
staining solution [0.25% (w/v) Coomassie Blue R250, 10% (v/v) glacial acetic acid and 
45% (v/v) methanol] for 3-4 h and then destained in 50% (v/v) methanol, 40% (v/v) water and 
10% (v/v) glacial acetic acid until the background was clear. 
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2.2.6.2 Glycine-based sodium dodecyl sulphate-polyacrylamide gel electrophoresis  
Sodium dodecyl sulphate (SDS) is an anionic detergent which gives uniform negative charge to 
proteins when bound to them (Pitt-Rivers and Impiombato, 1968). SDS also denatures the 
proteins into their individual polypeptide units. The expressed proteins and purified protein 
fractions collected were subjected to discontinuous SDS-PAGE according to the Laemmli 
method (Laemmli, 1970). The discontinuous gel system consisted of a 12% separating gels 
[12%  (w/v) acrylamide, 1.35% (w/v) bisacrylamide, 0.25 M Tris-Cl pH 8.8, 0.1% (w/v) SDS, 
0.05% (v/v) ammonium persulfate and 0.1% (v/v) TEMED] and 4% acrylamide stacking gels 
[4% (w/v) acrylamide, 0.36% (w/v) bis-acrylamide, 0.05 M Tris-HCl pH 6.8, 0.01% (w/v) SDS, 
0.005% (v/v) ammonium persulfate and 0.2% (v/v) TEMED]. The loading buffer [0.5 mM Tris-
HCl, 20% (v/v) glycerol, 10% (w/v) SDS, 100 mM β-mercapto ethanol, 0.05% bromophenol 
blue, pH 6.8] was mixed with the protein in the ratio 1:2 and then boiled at 100°C for 5 min 
before loading onto the gels. The gels were electrophoresed using the electrode buffer (anode 
and cathode) [250 mM Tris-HCl, 192 mM glycine, 0.1% (w/v) SDS (pH 8.3)] at 160 V for 
approximately 90 min using a PowerPac
TM
 Basic Bio-Rad electrophoresis system. The molecular 
weight markers used are the same as in section 2.2.6.1. The gels were then stained with 
Coomassie Brilliant Blue R-250 staining solution same as in section 2.2.6.1 for 3-4 h, followed 
by destaining with a 1:5:4 (acetic acid : methanol : water) solution overnight. 
 
2.2.7 Liquid Chromatography-Mass Spectrometry/ Mass Spectrometry 
Mass Spectrometry (MS) can be used to identify proteins through peptide mass fingerprinting 
(PMF) and sequence-specific peptide fragmentation. Mass spectrometry (MS) involves 
separation of samples according to their mass-to-charge (m/z) ratio. 
Liquid chromatography (LC) or gel electrophoresis are the standard approach to protein 
identification (Thiede et al., 2005). LC involves two phases namely a mobile phase and a 
stationery phase which is attached to a bed with the samples to be separated distributed 
selectively between both phases. It is a process whereby sample particles undergoes sorption and 
desorption on the stationary phase. Larger particles elute before the smaller ones.  
Liquid chromatography-Mass spectrometry (LC-MS) involves the combination of two 
techniques which are the separation technique of liquid chromatography (HPLC) and mass 
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analysis abilities of mass spectrometry. The use of this combined technique is essential because 
it is sensitive, accurate and can tolerate various levels of contaminants (Kaufmann, 1995). The 
12% SDS-PAGE gel of pure FL-heEF1β after electrophoresis was sent to CSIR (Council for 
Scientific and Industrial Research Pretoria, South Africa). An in-gel trypsin digest and LC-
MS/MS was carried out in order to determine the protein contents of the bands. The bands 
containing the protein to be analysed was extracted from the gel and destained using 50 mM 
ammonium bicarbonate (NH4HCO3)/50% methanol, after which 55 mM iodoacetamide in 
25 mM NH4HCO3 was used to carry out alkylation which was then exposed to in-gel digest using 
trypsin at 37
o
C overnight. The digest was then resuspended in 50% acetonitrile/5% formic acid 
solution which was analysed by rapid separation liquid chromatography using a Dionex Ultimate 
3000 RSLC system attached to a QSTAR ELITE mass spectrometer. Electrospray ionisation was 
used to ionise the peptide and the QSTAR ELITE mass spectrometer was used to measure the 
mass of the ions. Protein pilot using the Paragon search engine (AB Sciex) (Shilov et al., 2007) 
was used to match the obtained MS/MS spectra with proteins in a UniSwiss database supplied. 
Proteins with percentage confidence above 95% were reported for the bands analysed. 
 
2.2.8 Protein quantification 
2.2.8.1 Estimation of the molecular weight of the proteins 
The molecular weights of the proteins were derived from the equation of the line, from the graph 
of Log of molecular weights of the standards used in the gels against the distance travelled (cm). 
The distance travelled by the protein is measured from the electrophoretogram and substituted in 
the equation of the line to derive the molecular weight of the protein or can be interpolated from 
the graph. 
 
2.2.8.2 Determination of protein concentration 
The concentrations of the heEF1β proteins (FL-heEF1β, CT-heEF1β and NT- heEF1β) as well as 
heEF1γ proteins (CT-heEF1γ and NT-heEF1γ) were determined using a Jasco V-630 
spectrophotometer. The Beer-Lambert law was applied as follows: 
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𝐴 = ε𝑐𝑙 (2.1) 
 
A= εcl where A is the absorbance, ε is the molar extinction coefficient (M-1cm-1) at a given 
wavelength (usually 280 nm for protein detection), c is the molar concentration and l is the 
pathlength (cm).  
 
𝐶𝑜𝑛𝑐 (𝑚𝑔/𝑚𝑙) =
𝑆𝑙𝑜𝑝𝑒 × 𝑀𝑟
𝜀
 
(2.2) 
 
Slope is gotten from the equation of the line in the graph of absorbance versus wavelength. The 
molar extinction coefficients was derived theoretically from ExPASy ProtParam (Gasteiger et 
al., 2005). For heEF1β proteins: 2× 29,910 M-1cm-1 for FL-heEF1β because it is a dimer, 48,930 
M
-1
cm
-1
 for CT-heEF1β and 15930 M-1cm-1 for NT-heEF1β while for heEF1γ proteins: 86860 
M
-1
cm
-1 
for FL-heEF1γ, 37930 M-1cm-1 for NT-heEF1γ and 48930 M-1cm-1 for CT-heEF1γ.  
 
Absorbance at 280 nm was measured for a serially diluted solution of the protein solution using 
doubling dilution method and the concentration determined by fitting a linear regression to six 
points of absorbance versus wavelength. The buffer readings were subtracted from the 
absorbance readings used for the concentration determination. The determined interference at 
340 nm was subtracted from the measured absorbance at 280 nm to correct the effects of light 
scattering. Substitution of the corrected absorbance, the extinction coefficient, and the pathlength 
(1 cm) into the Beer-Lambert law (above) yields the molar concentration (M) of soluble protein. 
 
2.2.9 Determination of protein quality using absorbance spectrometry 
The absorbance of the proteins was monitored at wavelength 260 nm–340 nm to check for DNA 
contamination and protein aggregation. 5 μM of pure protein in 10 mM Tris-HCl pH 7.4 was 
assessed using the Jasco V-630 spectrophotometer (Analytical Solutions). The data was collected 
at 20°C and are an average of three accumulations. All the data collected were buffer corrected 
by subtracting the data of the blank solution from the protein data. A graph of absorbance against 
wavelength was plotted. 
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2.2.10 Structural characterisation 
2.2.10.1 Far-UV circular dichroism 
Circular dichroism (CD) spectroscopy is used to analyse the secondary structure of the protein by 
using optically active molecules to measure the difference in absorbance of left and right 
circularly polarised light (Creighton, 1997). CD spectroscopy provides information about the 
environments of the chromophores of the aromatic amino acids as well as the contributions from 
disulfide bonds (Kelly and Price, 1997). Aromatic amino acids and disulfide groups have 
characteristic absorption bands in the near-UV range (250-300 nm). 
 
The protein backbone absorbs strongly in the far-UV region (170-250 nm) which leads to 
characteristic secondary structure spectra (Woody, 1995). This wavelength range thereby gives a 
good indication of the secondary structural content of proteins such as α-helices and β-sheets. 
Proteins that have high α-helical content display characteristic minima at 208 and 222 nm and a 
strong peak at 190 nm whereas β-sheets give one trough near 217 nm and a peak in the 195-200 
nm range (Woody, 1995). 
 
Secondary structure content of FL-heEF1β, CT-heEF1β and NT-heEF1β were assessed using 
far-UV CD. Measurements were performed using Jasco J1500 spectropolarimeter (Jasco, Tokyo, 
Japan) at 20°C in the wavelength range of 190–250 nm. Stock solutions of the proteins FL-
heEF1β, CT-heEF1β and NT-heEF1β were dialysed against buffer J (0.1 M Tris-HCl pH 7.4) 
which was filtered using a 0.2 μm filter to remove particles which can affect the polarisation of 
light. The far-UV CD spectra of the proteins were collected five times using a 2 mm pathlength 
quartz cuvette with a data pitch of 0.2 nm, scanning speed of 100 nm.min
-1
, band width of 
0.5 nm and 1 sec response time. All spectra were buffer corrected by subtracting the spectra of 
the blank solution (0.1 M Tris-HCl pH 7.4) from the protein spectra. The raw CD data was 
converted to mean residue ellipticity [θ] using the following formula. 
 
[𝛩]𝑀𝑅𝐸 =  
100𝜃
𝑐𝑛𝑙
 
(2.3) 
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Where θ is the CD milli degree, c is the protein concentration, n is the number of residues and l 
is the pathlength in cm. The quantity of secondary structure of the proteins was estimated using 
Dichroweb algorithm. The raw far-UV CD data was submitted to the server and deconvoluted 
using the CONTILL algorithm implemented in the Dichroweb server (Whitmore and Wallace, 
2004).  
 
 
2.2.10.2 Fluorescence spectroscopy 
 
The naturally occurring fluorophores in proteins are tryptophan, tyrosine and phenylalanine. 
Fluorescence occurs when a molecule is excited from the ground state and returns to the ground 
state as emission of light at a longer wavelength (Lackowicz, 1983). Fluorescence can be used to 
analyse the tertiary structure of proteins particularly changes in the local environment of innate 
fluorophores (Joseph and Lakowicz, 1999). Phenylalanine has a small quantum yield therefore 
its emission is not noticeable while that of tyrosine is slightly higher than that of phenylalanine, 
Trp residues are roughly five times more sensitive than Tyr, mainly because Trp has a molar 
extinction coefficient of 5.5×10
3
 M
-1
cm
-1
 at 280 nm which is greater than the extinction 
coefficient for Tyr at 274 nm (Eftink, 1995). The indole ring of tryptophan is highly sensitive to 
solvent polarity (Lakowicz and Masters, 2008). Hence, fluorescence in the near-UV range is 
particularly sensitive to the environment of tryptophan residues. It depends on how many 
tryptophan residues and the region of the protein (buried or on the surface) where they are 
located (Creighton, 1997). A blue-shifted spectrum indicates that the tryptophan residue is buried 
in an environment which is nonpolar, while a red shifted spectrum indicates that the tryptophan 
residue is exposed in an environment which is polar. The tryptophan’s indole ring is highly 
sensitive to solvent polarity (Joseph and Lakowicz, 1999). Emission spectra of this residue 
reflect the polarity of its surrounding environment.  
 
ANS-based extrinsic fluorescence 
 
ANS (8-anilino-1-naphthalene sulfonate) is an hydrophobic dye used as an extrinsic fluorescence 
probe (Engelhard and Evans, 1995). The hydrophobic pockets in the proteins were assessed by 
extrinsic ANS fluorescence. ANS fluorescence is quenched in an aqueous or polar environment, 
but when it binds to a hydrophobic surface there will be an increase in the fluorescence quantum 
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yield and the maximum emission wavelength becomes blue-shifted (Gasymov and Glasgow, 
2007). Free ANS excited at 390 nm emits at 540 nm. However, when ANS binds to exposed 
hydrophobic sites on a protein, the emission is lowered to around 470 nm. The change in 
emission wavelength depends on the quantum yield of ANS and the hydrophobicity of the ANS 
binding sites available on the protein (Stryer, 1965). 
 
A stock solution of ANS was prepared in  buffer K [50 mM Tris-HCl pH 7.4, 0.5 M NaCl and 
0.02% (w/v) NaN3] away from light in accordance with the general procedure for 
spectrophotometrically determining the concentration of ANS using extinction coefficient (𝜀) of 
5000 M 
-1
cm
-1
 at 350 nm. Protein (5 μM) was incubated with 200 μM of freshly prepared ANS 
away from light for 60 min, to achieve equilibrium. A series of blanks were generated, each 
containing 200 μM ANS and treated in similar manner as the ANS-Protein samples. The samples 
were analysed using Jasco FP-6300 spectrofluorimeter with a 10 mm pathlength cuvette and 
200 nm.min
-1
 scan speed. Samples were excited at 380 nm with a slit width of 5 nm and emission 
spectra (average of 5 scans) were recorded from 390 to 600 nm. Spectra were produced from an 
average of three accumulations. The spectra were recorded at 20°C, buffer corrected, and are an 
average of three accumulations at a scan speed of 200 nm.min
-1
.  
 
ANS-protein binding curve was determined using varying concentrations of ANS (0-200 μM) 
titrated against fixed concentration (5 μM) of each protein construct. The fluorescence emission 
intensity at 465 nm were extracted and plotted against the ANS concentration and a single site 
ligand-binding curve was fitted based on the equation: 
 
𝐹𝑐𝑜𝑟  =  
𝐹𝑚𝑎𝑥  [𝑃𝑟𝑜𝑡𝑒𝑖𝑛]
𝐾𝑑  + [𝑝𝑟𝑜𝑡𝑒𝑖𝑛]
 
(2.4) 
 
Where Fcor is the corrected fluorescence, Fmax is the max fluorescence and Kd is the dissociation 
constant. Data fitting was done using Sigma plot v 13.0. 
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2.2.11 Size exclusion-high performance liquid chromatography 
Size exclusion chromatography (SEC) is a technique involving the separation of molecules based 
on their sizes in solution. Larger particles are eluted faster. Size exclusion high performance 
liquid chromatography (SE-HPLC) has more advantages such as reusable column without 
repacking and regeneration, increased speed of analysis and good resolution among others 
(Tayyab et al., 1991).  
The dynamic volume and quaternary structure of the proteins (FL-heEF1β, CT-heEF1β, NT-
heEF1β, FL-heEF1γ, CT-heEF1γ and NT-heEF1γ) were assessed using analytical SE-HPLC. 
The procedure was carried out on a LC Phenomenex HPLC column along with a Guard cartridge 
column. The column attached to a Shimadzu Prominence HPLC system (SPD20A) at a flow rate 
of 0.2-0.3 ml.min
-1
 was pre-equilibrated with buffer L [50 mM Tris- HCl, 0.02% (w/v) NaN3, 
10% (v/v) glycerol, 1 M NaCl, pH 6.8] which has been filtered and degassed. After equilibration 
the standard gel filtration marker was injected to calibrate the column. The standard gel filtration 
molecular weight marker containing the following proteins was used: thyroglobulin (670 kDa), 
γ-globulin (154 kDa), ovalbumin (44 kDa), myoglobulin (17 kDa) and vitamin B12 (1.35 kDa).  
The quaternary structure characteristics were determined by injecting 20 μl of each protein 
(5 µM) onto the column and eluted isocratically with the buffer at a flow rate of 0.2-0.3 ml.min
-1
 
for FL-heEF1β, CT-heEF1β, NT-heEF1β, NT-heEF1γ and CT-heEF1γ. The log of the molecular 
weight of the proteins was interpolated from the graph of molecular weights against retention 
time of the standards. 
2.2.12 Protein-protein and protein-ligand interaction  
Oxidised glutathione (GSSG) have been shown to be related to cellular oxidative stress as seen 
in some diseases such as tumorigenesis, multiple sclerosis (Jones et al., 2000). The column was 
equilibrated with the buffer M [50 mM Tris- HCl, 0.02% (w/v) NaN3, 10% (v/v) glycerol, 1M 
NaCl, 5 mM GSSG pH 6.8]. Each of the proteins (FL-heEF1β, CT-heEF1β, NT- heEF1β, CT-
heEF1γ and NT- heEF1γ) was incubated with 20 mM GSSG for 30 min at 20°C and then loaded 
onto the column. Protein-protein interaction between heEF1β and heEF1γ was also assessed. 
Equimolar amounts of FL-heEF1β and CT-heEF1γ, CT-heEF1β and NT-heEF1γ, NT- heEF1β 
and CT-heEF1γ, NT- heEF1β and NT-heEF1γ, FL-heEF1β and NT-heEF1γ were prepared and 
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incubated for 30 min at 20°C and then injected into the SE-HPLC column in the presence and 
absence of oxidised glutathione ligand.  
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CHAPTER 3 
Results 
 
3.1 Introduction 
 
The biochemical and biophysical characterisation of target proteins are important elements in 
improving the success rates of their structural studies. Biophysical characterisation of heEF1β 
involved the construction of three E. coli expression vector systems for recombinant expression 
of the FL-, NT- and the CT- regions of the protein using pET-28a for FL and NT and pET-11a 
plasmid for CT. The proteins were purified to homogeneity to prevent interference by 
contaminants. Quantitative and qualitative analysis of the protein was then carried out before the 
structural characterisations of the proteins. 
 
3.2 Vector sequencing 
 
The chromatograms received from Inqaba Biotec (Pretoria, South Africa) contained gene 
sequences, which were translated using the online server ExPAsy Translate (Artimo et al., 2012). 
The translated amino acid sequences were then compared with the sequence in the database 
using the basic alignment search tool (BLAST). The proteins sequences of both FL-heEF1β and 
FL-heEF1γ have very close sequence identity with that found in the database. 
 
3.3 Protein expression and purification 
The conditions for producing the maximum amount of soluble protein for all the proteins were 
found to be cold induction with a final concentration of 0.5 mM IPTG and expression at 30°C for 
6 h post-induction (Figure 3.1). The soluble protein was partitioned into E. coli inclusion bodies 
on inducing at 37°C. Most of the recombinant proteins were found in the soluble cell lysate. The 
controls are cells cultured without IPTG and they did not show any detectable over-expressed 
protein.  
 
All the proteins (FL-heEF1β, NT-heEF1β, CT-heEF1β, NT-heEF1γ and CT-heEF1γ) were 
purified by IMAC and as shown on the SDS-PAGE electrophoretogram. IMAC purification of    
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Figure 3.1: Tricine SDS-PAGE electrophoretogram showing production of FL-heEF1β. Induction for 
optimal protein production, when exposed to 0.5 mM IPTG concentration for varying time periods (2 h, 4 
h and 6 h) at 37
o
C. I represents insoluble and S represents soluble. The arrow points at the protein band 
between 25-35 kDa corresponding to the theoretical weight.  
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the protein was performed using HisTrap columns. The hexahistidine-tagged fusion protein binds 
to the nickel or cobalt ions which are covalently attached to the matrix and dilution was 
monitored at 280 nm (Figure 3.2). The hexahistidine-fusion protein has stronger affinity for the 
nickel or cobalt ions and outcompetes the low concentration of imidazole and protein 
contaminants. The proteins are eluted with a high concentration of imidazole (350 mM).  
 
3.3.1 FL-heEF1β 
The FL-heEF1β have more than one band as seen in the  IMAC SDS-PAGE electrophoretogram, 
(Figure 3.3)  which indicates the presence of contaminants hence the need for other purification 
methods. DEAE-agarose ion exchange chromatography was shown to be effective in purifying 
FL-heEF1β proteins to homogeneity as seen in Figure 3.4.  
 
3.3.2 NT-heEF1β 
The NT-heEF1β protein also required further purification as observed from the IMAC SDS-PAGE 
electrophoretogram (Figure 3.5) there was more than one band. DEAE-agarose ion exchange 
chromatography was also used for second step purification (Figure 3.6). 
 
3.3.3 CT-heEF1β 
The CT-heEF1β protein required only one purification step which was IMAC (Figure 3.7). Only  
one band was seen in the electrophoretogram indicating that the protein is pure. 
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Figure 3.2: IMAC purification profile of FL-heEF1β.The solid line represents the absorbance at 280 nm 
while the dashed lines represent the imidazole concentration. Peak 1 is the protein injection, peak 2 is the 
Triton X-100 wash and peak 3 is the one-step imidazole elution. The soluble fraction subsequent to cell 
lysis was loaded onto a HisTrap nickel column pre-equilibrated with 50 mM Tris-HCl, 0.02% (w/v) 
NaN3, 10% (v/v) glycerol, 1M NaCl, 40 mM imidazole pH 7.4. The histagged proteins bind to the column 
while the non-specific proteins pass through as their binding affinity is relatively weak as seen in peak 1. 
Absorbance increases again during the wash because of the detergent Triton X-100 present in the washing 
buffer, which is used to remove non-specific bound proteins or proteins involved in hydrophobic 
interactions with the column as seen in peak 2. Afterwards the equilibration buffer was used to remove 
excess Triton X-100 and the absorbance decreases again until it returned to baseline. A high 
concentration of imidazole (350 mM) displaces the proteins from binding to the column. The proteins 
elutes in a sharp peak as seen in peak 3. 
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Figure 3.3: Tricine SDS-PAGE electrophoretogram showing the IMAC purified samples of FL-heEF1β, 
where MW represents the molecular weight marker, P represents pellet, S represents the supernatant, Ft 
represents the flow through and 1-6 represents the eluted fractions of the protein collected at increased 
imidazole concentration (300 mM). The red outlined bands are impurities. 
 
 
 
 
Figure 3.4: 12% Glycine SDS-PAGE electrophoretogram showing the DEAE-agarose ion exchange 
chromatography purified samples of FL-heEF1β. IMAC purified samples were pooled together and 
dialysed (16 h, 4
o
C) against the dialysis buffer (50 mM Tris-HCl, 0.02% (w/v) NaN3, 10% (v/v) glycerol, 
1 mM EDTA, 1 mM EGTA, 500 μl TCEP pH 7.4). Purified samples of FL-heEF1β were eluted with 
0.4 M NaCl. Where Mw is the molecular weight markers, PF represents the pooled fractions of IMAC 
purified FL-heEF1β samples, Ft is the flow through while 1-7 represents the eluted protein fractions; 
fractions 1-4 still have some impurities while fractions 5-7 are  pure samples of FL-heEF1β.  
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Figure 3.5: Tricine SDS-PAGE electrophoretogram used to assess the IMAC purified samples of NT-
heEF1β where MW represents the molecular weight marker, S represents the supernatant, Ft represents 
the flow through and 1-3 represents the eluted fractions of the protein collected at increased imidazole 
concentration (300 mM). The red highlighted bands and other smaller bands are contaminants, hence the 
need for further purification step. 
 
 
 
 
 
Figure 3.6: 12% Glycine SDS-PAGE electrophoretogram showing the DEAE-agarose ion exchange 
chromatography purified NT-heEF1β samples. IMAC purified samples were pooled together and dialysed 
(16 h, 4
o
C) against the dialysis buffer (50 mM Tris-HCl, 0.02% (w/v) NaN3, 10% (v/v) glycerol, 1 mM 
EDTA, 1 mM EGTA, 500 μl TCEP pH 7.4). PF represents the IMAC purified samples pooled together 
and dialysed. FT is the flow through; it has no band indicating that the protein binds completely to 
DEAE-agarose. 1-7 represent the purified samples of NT-heEF1β eluted with 0.4 M NaCl.  From the gel, 
only one band is observed for all the fractions collected indicating that the protein is very pure. 
 
35 
 
 
 
 
 
Figure 3.7: 12% Glycine SDS-PAGE electrophoretogram showing the heEF1β proteins used in this 
study: FL-heEF1β, NT-heEF1β and CT- heEF1β. MW is the molecular weight marker. Lane 1, lane 3 and 
lane 5 are the lysate samples of FL-heEF1β, NT-heEF1β and CT- heEF1β respectively while lane 2, lane 
4 and lane 6 are the purified samples of FL-heEF1β, NT-heEF1β and CT- heEF1β respectively. 
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3.3.4 NT-heEF1γ and CT-heEF1γ 
The NT-heEF1γ was purified by IMAC after which the eluted protein factions were pooled 
together and further purified by GSH-Agarose chromatography (Figure 3.8) while the CT-
heEF1γ protein was purified to homogeneity by IMAC alone (Figure 3.9). 
 
3.4 Quantitative and qualitative evaluation of the purified proteins 
A graph of the Log of the molecular weight of the standards against distance migrated on the gel 
(cm)  in Figure 3.4 was plotted, and used to determine the molecular weight of the protein (FL-
heEF1β) as seen in Figure 3.10. The equation of the line from the graph; 
𝑦 = −0.1219𝑥 + 2.1796 (3.1) 
 
 
where 𝑥 is the distance (cm) migrated by the protein on the gel and y is the Log of molecular 
weight of the protein. From the electrophoretogram (Figure 3.4) the distance migrated by the 
protein was substituted into equation 3.1. Therefore the molecular weight of the protein was 
computed to be approximately 28 kDa. 
 
About 7.0 g of wet cells was obtained in 1 liter culture for FL-heEF1β, while 10.4 g and 9.5 g of 
wet cells were obtained for CT-heEF1β and NT-heEF1β respectively. FL-heEF1β had a 
reasonable level of soluble expression which yielded approximately 28.5 mg of protein while 
CT-heEF1β and NT-heEF1β yielded approximately 71 mg and 65 mg of protein respectively.  
Protein concentration was determined by serial dilution. A graph of absorbance (A280–A340) 
against dilution factor was plotted for the FL-heEF1β protein. Slope was derived from the 
equation of the line (Figure 3.11). Equation of the line was derived to be: 
 
𝑦 = 4.4663𝑥 + 0.0019 (3.2) 
Slope was derived to be 4.4663 and substituted in equation 3.2 above 
 
𝐶𝑜𝑛𝑐 (𝑚𝑔/𝑚𝑙) =
4.4663 × 67000
2 × 29910
= 5.0024 𝑚𝑔/𝑚𝑙 
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𝐶𝑜𝑛𝑐 (𝑚𝑜𝑙/𝐿) =
𝑟𝑒𝑎𝑐𝑡𝑖𝑛𝑔 𝑚𝑎𝑠𝑠
𝑚𝑜𝑙𝑎𝑟 𝑚𝑎𝑠𝑠
=
5.0024
67000
= 0.000075 𝑚𝑜𝑙/𝐿~75 𝜇𝑀 
Therefore concentration of FL-heEF1β was computed to be 75 μM. 
 
The protein quality was determined using absorbance spectrometry, which is a graph of 
absorbance against wavelengths 260-340 nm to ensure that there was no DNA contamination 
or protein aggregation (Figure 3.12). Following protein expression, purification, quantity and 
quality evaluation, the identity of the proteins was confirmed by peptide sequencing mass 
spectrometry in CSIR (Pretoria, South Africa) to be heEF1β and heEF1γ (Figure 3.13). The 
results showed that all the peptides were identified with >95% confidence. 
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Figure 3.8: Tricine SDS-PAGE electrophoretogram showing the eluted pure fractions of NT-heEF1γ. S 
represents the supernatant, FT represents the flow through and 1,2,3 and 4 represents the eluted pure 
fractions of NT-heEF1γ. The arrow points to the band of the protein which falls between 25 and 35 kDa. 
 
  
 
 
 
 
 
 
Figure 3.9: Tricine SDS-PAGE electrophoretogram showing the eluted pure fractions of CT-heEF1γ. S 
represents the supernatant, FT represents the flow through and 1and 2 represent the eluted pure fractions 
of CT-heEF1γ. The arrow points to the protein band. 
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Figure 3.10:  Graph of Log of molecular weight against distance migrated by the protein on the gel in 
Figure 3.4. The equation of the line was used to compute the molecular weight of the protein, by 
substituting the value of the distance migrated on the gel (cm) into the equation. 
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Figure 3.11: A graph of absorbance against dilution factor. The value of R
2 
was derived to be 0.9999~1 
and the slope which is 4.4663 was used to determine the concentration of the protein FL-heEF1β. Six 
dilutions of the proteins was prepared by adding 100 μl of the protein to 900 μl of buffer and mixed 
thoroughly. 500 μl of the sample was taken and added to 500 μl of buffer and was done serially in five 
Eppendorf 
TM
 tubes. Absorbance at 340 nm was subtracted from the absorbance at 280 nm to remove the 
interferences by noise or light. 
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Figure 3.12: A graph of absorbance at 280 nm against wavelength for FL-heEF1β protein. No DNA 
contamination was observed because there was no peak formed at 260 nm which is the wavelength at 
which DNA absorbs UV light. There was no protein aggregation because there was no peak formed at  
340 nm. 
 
 
 
 
 
Figure 3.13: A chart showing the mass spectrometry results of the samples sent to CSIR Pretoria. More 
than 40% of the peptides are heEF1γ and more than 90% are heEF1β. All peptides were identified with 
>95% confidence. The keratin impurities could be from the skin while the trypsin was used to breakdown 
the proteins to smaller peptides. 
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3.5 Structural characterisation 
  
Far-UV circular dichroism spectroscopy was used to analyse the secondary structure of the 
protein. Fluorescence spectroscopy was used to provide information on the tertiary structure by 
looking at changes to the local environment of tryptophan residues. Analytical size exclusion 
high pressure liquid chromatography (SE-HPLC) was used to determine the quaternary structure 
of the protein and to assess the protein-protein interactions.  
 
3.5.1 Secondary Structure characterisation by far-UV CD  
Information on the secondary structure of the FL-heEF1β, NT-heEF1β and CT-heEF1β was 
obtained using far-UV CD at pH 7.4 and 20
o
C. Far-UV CD spectra of the proteins denatured in 
8 M urea were also collected to make certain that the spectra for the native protein are 
distinguished. The far-UV CD spectra for all the three proteins were recorded over a far-UV CD 
wavelength range of 190 nm to 250 nm. The results from the Figure 3.14 indicate that the 
heEF1β protein is rich in alpha helices because of the negative peak at 208 nm. The FL-heEF1β 
and NT-heEF1β display minima at 208 and 222 nm, and a peak at 190 and 195 nm respectively, 
which is typical of proteins with predominant alpha helical content. The spectra data CT-heEF1β 
has only one negative peak at 208 nm and a peak at 190 nm, which indicates a mix of alpha helix 
and β sheets. The CD spectra data were deconvoluted using the CONTILL algorithm in 
Dichroweb as seen in Table 2. The data suggest that FL-heEF1β and NT-heEF1β are 
predominantly α-helical, which corresponds to the spectra profile. The data for CT-heEF1β is not 
conclusive because the rmsd is above 0.1 (Table 2). 
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Figure 3.14: Far-UV CD spectra of FL-heEF1β (red), NT-heEF1β (green) and CT-heEF1β (grey). 
Spectra were collected using samples of 2 μM protein in 0.1 mM Tris-HCl pH 7.4. The similar spectra 
(red and green) indicate that both proteins have similar secondary structure which is predominantly α-
helix.  
 
 
Table 2: Summary of the secondary structure content calculated using the CONTILL algorithm 
implemented in the Dichroweb server. Normalised root-mean-square deviation (NRMSD) indicates the 
goodness of fit of calculated data to experimental data, with <0.1 acceptable as good fit. 
Protein construct Secondary structure content (%) rmsd 
α helix β strand β turns Unordered 
FL-heEF1β 56.1 21.0 23.0 7.9 0.04 
NT-heEF1β 52.4 9.2 36.3 0.2 0.02 
CT-heEF1β 38.5 27.9 14.9 17.2 0.12 
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3.5.2 Tertiary structure characterisation by extrinsic tryptophan ANS fluorescence 
ANS (8-anilino-1-naphthalene sulfonate) is an amphipathic dye used as an extrinsic fluorescence 
probe because it binds to accessible hydrophobic pockets in a protein (Gasymov and Glasgow, 
2007). Increase in quantum yield and simultaneous blue shift in the maximum emission 
wavelength (λmax) of ANS fluorescence from 510 nm (free ANS in a polar environment) to 480 
nm indicates that the protein binds to ANS. The result from Figure 3.15 shows that both FL-
heEF1β and CT-heEF1β have accessible binding pockets because of the increase in quantum 
yield and change in the λmax of the fluorescence spectra from 510 to 480 nm. There was a slight 
increase in quantum yield for NT-heEF1β, but it does not have any binding pocket accessible to 
ANS because the λmax remained at 510 nm. The apparent increase in quantum yield could be due 
to the interaction between the dye and the cluster of highly charged surface available amino acids 
in the protein. To further quantify heEF1β-ANS binding, a fixed amount of heEF1β was titrated 
with increasing amounts of ANS and the resulting curve was fitted using a single or multiple site 
binding models implemented on Sigma v 12 (Figure 3.16). The results show that the binding of 
ANS to the accessible hydrophobic pocket in heEF1β follows a single dose dependent hyperbolic 
profile. ANS concentration tends to saturate at concentration >200 μM. The fit statistics satisfies 
a single site binding, yielding a Kd of ~70.5 μM of ANS. 
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Figure 3.15: Extrinsic ANS Fluorescence emission spectra. Spectra of 200 μM ANS bound to 2 μM FL-
heEF1β (red), CT-heEF1β (grey) and NT-heEF1β (green). ANS was selectively excited at 390 nm and the 
spectra recorded over the 400-600 nm range using an excitation and emission bandwidth of 5 nm. Each 
spectrum is the average of three accumulations of three replicate samples in 50 mM Tris-HCl pH 7.4 
containing 0.5 M NaCl and 0.02 % (w/v) NaN3. The spectra of protein bound to ANS were corrected for 
the fluorescence contribution from free unbound ANS.  
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Figure 3.16: Fluorescence signal of FL-heEF1β as a function of ANS concentration. 2 μM FL-heEF1β 
was titrated with increasing ANS concentration excited at 295 nm and emission at 480-510 nm. Each data 
point represents an average of three replicate experiments. The data was fitted to a hyperbolic function 
using Sigma Plot v 12. Kd for ANS binding to the FL-heEF1β is 70.5 μM 
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3.5.3. Quaternary structure characterisation by SE-HPLC 
Analytical size exclusion high performance liquid chromatography (SE-HPLC) was used to 
determine the oligomeric state of heEF1β. The gel filtration standards were used to calibrate the 
column and a graph of the Log of molecular weights against retention time was plotted (Figure 
3.17). From the individual chromatogram of the proteins as seen in Figure 3.18 the retention 
times were used to interpolate the molecular weight of the protein or by using the equation of 
line. The FL-heEF1β eluted with a double peak at 62 kDa and 25 kDa corresponding to a 
possible homodimer and monomer, with the dimer being the predominant quaternary structure at 
the condition used for the analysis. CT-heEF1β eluted at a single peak at 14 kDa indicating a 
monomeric state. NT-heEF1β which is approximately 15 kDa in its monomeric form, eluted at a 
peak approximately 30 kDa which is indicative of a homodimer as seen in Figure 3.18b. From 
the overall results it indicates that there was no high order oligomeric states of heEF1β constructs 
and that the observed masses are comparable to the theoretically predicted monomeric masses of 
each construct. The NT-heEF1γ eluted at a peak approximately 23 kDa which is a monomer and 
as a dimer at 46 kDa in the presence of GSSG. CT-heEF1γ eluted at 19 kDa which is 
predominantly monomeric (Figure 3.19). 
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Figure 3.17: (a) Chromatogram of the gel filtration standards resolved by SE-HPLC at a flow rate of 0.2-
0.3 ml.min
-1
 at 20
 o
C. The standards were used to calibrate the column. Standards with larger weights are 
eluted first. (b) Graph of Log of molecular weight of gel filtration standards against retention time (min) 
was used to determine the molecular weight of the desired protein.  670 kDa-Thyroglobulin (bovine), 154 
kDa- γ-globulin, 44 kDa-Ovalbumin, 17 kDa-Myoglobulin, 1.35 kDa-Vitamin B12 .The molecular weight 
of the protein can be interpolated from the line graph, if the retention time is known.    
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Figure 3.18: Chromatograms showing the quaternary structure characterisation of heEF1β resolved by 
SE-HPLC. (a) Chromatogram of FL-heEF1β (red) and CT-heEF1β (grey) showing that FL-heEF1β is 
dimeric at 62 kDa and monomeric at 25 kDa which implies that it is predominantly dimeric, while CT-
heEF1β is monomeric at 14 kDa.  (b) Chromatogram of NT-heEF1β showing that the protein is dimeric.  
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Figure 3.19: Individual chromatograms of the heEF1γ proteins using SE-HPLC. (a) Chromatogram of 
NT-heEF1γ, the protein is monomeric at 23 kDa (b) Chromatogram of NT-heEF1γ in the presence of 
GSSG ligand. The protein is dimeric at 46 kDa (c) Chromatogram of CT-heEF1γ which is also 
predominantly monomeric at 19 kDa.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
51 
 
3.6 Functional characterisation by protein-protein interaction  
Analytical SE-HPLC was also used to characterise the protein-protein interaction between 
heEF1β and heEF1γ. The heEF1β protein does not interact with 19 kDa CT-domain of heEF1γ 
because the peaks in the chromatogram corresponds to the dimeric form of heEF1β (64 kDa), the 
monomeric form of heEF1β (23 kDa) and the monomeric form of CT-heEF1γ (19 kDa) as seen 
in Figure 3.20. There is no interaction between CT-heEF1β and NT-heEF1γ because the peaks of 
the mixture corresponds with the individual peaks for the monomeric NT-heEF1γ (23 kDa) and 
CT-heEF1β (14 kDa) as observed in Figure 3.20b. The heEF1β interacts with NT-heEF1γ and 
this interaction takes place at the N-terminus domain of both proteins. The complex between 
dimeric heEF1β and monomeric NT-heEF1γ is approximately 195 kDa, which is ~44% larger 
than the predicted mass of 110 kDa, assuming FL-heEF1β-NT-heEF1γ complex assumes γ:ββ:γ 
(monomeric NT-heEF1γ and dimeric FL- heEF1β) conformation. The interaction between FL- 
heEF1β and NT-heEF1γ is not affected by the dimerisation of NT-heEF1γ (46 kDa) in the 
presence of oxidised glutathione (GSSG) as seen in Figure 3.20d. However the sizes of the 
complex increases to 230 kDa which is ~36% larger than the predicted size of 156 kDa if the 
complex between FL-heEF1β and NT-heEF1γ assumes γγ:ββ:γγ (dimeric FL- heEF1β and NT-
heEF1γ) conformation. No higher oligomeric state was observed in the interaction between FL- 
heEF1β and NT-heEF1γ. 
 
When NT-heEF1β was incubated with NT-heEF1γ for complex formation, the mixture resolved 
in three distinct peaks which are 23 kDa, 129 kDa and >670 kDa corresponding to the 
monomeric NT-heEF1γ, a possible γ:ββ:γ (monomeric NT-heEF1γ and dimeric NT-heEF1β) 
conformation and high order oligomers, respectively as seen in Figure 3.21. The 129 kDa peak is 
32% greater than the expected 76 kDa size for γ:ββ:γ conformation. 
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Figure 3.20: Protein-protein interaction chromatograms resolved by SE-HPLC. (a) FL-heEF1β (red) and 
CT-heEF1γ (black) and the dotted line indicating no interaction because the peaks correspond to the 
individual proteins (FL-heEF1β and CT-heEF1γ). (b) NT-heEF1γ (blue) and CT-heEF1β (grey) and the 
dotted line indicating no interaction because the peaks correspond to the individual proteins (NT-heEF1γ 
and CT-heEF1β). (c) FL-heEF1β and NT-heEF1γ interaction and the dotted line indicating the interaction 
resolved at 195 kDa, while the other peaks correspond to the individual protein. (d) FL-heEF1β and NT-
heEF1γ interaction in the presence of GSSG. The dotted line indicates the interaction resolved at 230 kDa 
while the other peak corresponds to the FL-heEF1β.  
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Figure 3.21: Protein-protein interaction (NT-heEF1β and NT-heEF1γ) resolved by SE-HPLC. The dotted 
lines represent the interaction profile of both proteins which resolved in three different peaks: 22 kDa 
(monomeric NT-heEF1γ), 129 kDa (monomeric NT-heEF1γ and dimeric NT-heEF1β) and high order 
oligomer > 670 kDa. The green line is the NT-heEF1β which is dimeric while the blue line is the NT-
heEF1γ respectively. 
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CHAPTER 4 
 Discussion and conclusion 
 
 
4.1 Discussion 
Codon harmonisation of the gene encoding the proteins was very vital for the expression of 
soluble proteins. Heterologous protein expression could lead to the formation of insoluble 
aggregates and low expression of soluble proteins due to differences in identical codon usage 
between the expression and natural host. The plasmids pET-28a and pET-11a were used to clone 
the genes containing the proteins in E. coli JM109 cells and are ampicillin and kanamycin 
resistant respectively. JM109 cells are not expression cells hence the need to extract the plasmid 
DNA from it. They both have N-terminal histagged thrombin cleavage which had no effect on 
the expression and purification of the proteins. The thrombin cleavage site on the NT-domain 
was to ensure that there were minimal changes in the amino acid composition of the protein after 
purification. In this study the thrombin was not cleaved and it had no effect on the structure and 
function of the proteins. Site-directed mutagenesis was used to create the NT-heEF1β because it 
was cheaper purchasing the plasmid. A stop codon was encoded at lys 79 because it is easier to 
create a stop codon at the lysine residue by changing AAA→TAA.  
 
Expression of pET-28 plasmid vector which is kanamycin resistant with FL-heEF1β and NT-
heEF1β and pET-11a vector which is ampicillin resistant with CT-heEF1β insert in E. coli BL21 
(DE3) yielded reasonable levels of proteins which could be due to the codon harmonisation of 
the gene and using certain expression conditions such as cold induction, 0.5 mM IPTG and 
expression at 30oC for 6 h post-induction. Protein aggregation was not encountered and minimal 
amount of protein was found in the insoluble lysate.  
 
Isolation and purification of proteins is crucial and central to structure-function studies such as 
enzymology, protein-protein or protein-ligand interactions. A low concentration of imidazole 
was used in the equilibration buffer [50 mM Tris-HCl, 0.02% (w/v) NaN3, 10% (v/v) glycerol, 
1 M NaCl, 40 mM imidazole, pH 7.4] to get rid of non-specific proteins binding to the column 
since imidazole has a higher affinity for the nickel ions than the protein. Cellular DNA fragments 
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that may have bound to the protein during sonication were removed by high concentration of salt 
(1 M NaCl) in the equilibration buffer. Salt wash is of great importance because the sodium and 
chloride ions interact with the exposed charged side chains of the protein thereby preventing it 
from interacting with the negatively-charged DNA backbone which then passes through the 
column. Small amount of the protein was found in the insoluble fraction and could be due to the 
formation of inclusion bodies as a result of incorrect folding of the proteins. Two step 
purification systems was carried out because of the extra bands seen on the 12% glycine SDS-
PAGE electrophoretogram after IMAC purification which could be as a result of impurities.  
 
For FL-heEF1β and NT-heEF1β the second purification step was DEAE-agarose ion exchange 
chromatography which is an anion exchanger. The heEF1β protein has a pI of 4.88, which means 
that the protein is negatively charged and hence can bind to the positively charged DEAE resin. 
The pure protein was eluted with high salt (NaOH) concentration. Non-specific proteins and 
impurities that did not bind to the resin passed through the column. The second purification step 
for NT-heEF1γ is GSH-agarose affinity chromatography because it has a GST-like NT-domain 
which has affinity for glutathione. Bound proteins were eluted with 10 M glycine-NaOH instead 
of using glutathione because of the presence of glutathione in the background. Eluted protein 
fractions were collected and their pH immediately adjusted to ~7.5 by adding 1 M Tris-HCl pH 
7.4 at 25% (v/v) to prevent the loss in the secondary and tertiary characteristics of the protein due 
to increase in pH.  
Protein quantification was evaluated by determining the concentration of the protein using serial 
dilution. Large quantities of the protein was obtained for structural studies and could be due to 
the over expression of the soluble proteins.  
 
Confirming the integrity of the protein at the secondary, tertiary and quaternary structural levels 
provide valuable information required for further protein structure and function studies. The far-
UV CD data confirmed that heEF1β is predominantly α-helical and the NT-heEF1β construct 
used in this study is also predominantly α-helical; and putting into context the structure of the C-
terminus domain, the entire heEF1β should be rich in α-helices and random coils. When heEF1β 
is divided into an NT- and a CT- domain, the secondary structure content of both domains 
altered and does not sum up to the individual secondary structure in the full length polypeptide. 
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The reduction in the α-helical content of the NT-heEF1β could be as a result of formation of β-
strands and β-turns secondary structures (Table 2). Also, the acid rich region in the NT-heEF1β 
construct could also have become more unordered in the absence of the CT-domain of the 
protein. The reason why the truncation of heEF1β resulted in the formation of more unordered 
region and its implication with regards to protein-protein interaction with the γ subunit of eEF1 
complex have not been ascertained.  
 
The tertiary structure of heEF1β was examined with the aim of identifying possible accessible 
hydrophobic pockets in the protein. This may provide us with an insight into the type of forces 
responsible for the formation of heEF1βγ complex. ANS was used as an extrinsic fluorescence 
probe. The presence of hydrophobic cavities accessible to ANS may indicate that the interaction 
between β and the γ subunit of the eEF1β complex could be chiefly driven by hydrophobic 
interaction (Slavik et al., 1982; Gasymov and Glasgow, 2007), although it depends on which 
region of heEF1β. The absence of ANS cavities may indicate that ionic or electrostatic forces 
may be the mediating force behind such protein-protein interaction. There was interaction 
between heEF1β and ANS as seen in Figure 3.15 above, which indicates accessible hydrophobic 
clefts in heEF1β. These hydrophobic clefts appear to be in the CT-domain where heEF1β 
interacts with the GTPase α-subunit (van Damme et al., 1992). The binding of ANS to the 
hydrophobic pocket in the C-terminus follows a single site binding model as seen in Figure 3.16, 
which suggests that ANS interacts with a single site in heEF1β. The absence of any hydrophobic 
cavity accessible to ANS in the N-terminus region of heEF1β could indicate that electrostatic 
forces may be involved in the formation of heEF1βγ complex. This could mean that the 
interaction could be at the acid-rich cluster. 
 
The quaternary structure determination using analytical SE-HPLC was done at pH 6.8 because 
the matrix of the column disintegrates at pH above 7.0. The resolution of the column is adequate 
enough to enable precise estimation of the oligomeric state of a protein between 1.5 kDa and 
670 kDa. The CT-heEF1β elutes as a monomer with a tumbling volume consistent with the 
theoretically predicted size, while the FL-heEF1β is dimeric with an apparent molecular weight 
of ~62 kDa. This indicates that the NT-domain of heEF1β could be responsible for the 
dimerisation of the protein. In the absence of any high order oligomeric states of heEF1β, the 
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GST-like fold found in the NT-domain of heEF1β could be the initiator of dimer formation in 
heEF1β. This region is not found in heEF1δ, which resolves as a high order oligomer with 
molecular weight >670 kDa. Moreover, the absence of the CT-domain of heEF1β did not prevent 
the dimerisation of NT-heEF1β, neither did the secondary structure modifications observed in 
NT-heEF1β prevent its dimerisation. Structural prediction of heEF1β suggests that part of the 
NT-domain shares similar fold with the α-helical CT-domain of GSTs which could be 
responsible for dimerisation of the protein. NT-heEF1γ undergoes ligand-induced dimerization 
in the presence of oxidised glutathione. This ligand-induced dimerization did not affect the 
tendency of NT-heEF1γ to form a complex with NT-heEF1β. Efforts to replicate this data using 
reduced glutathione did not yield conclusive results.  
 
The interaction between the β and the γ-subunits was examined using analytical SE-HPLC, 
which has a very high resolving power. Although it has been postulated that the interaction 
between heEF1β and heEF1γ occur at the NT-domains of both proteins (van Damme et al., 
1990), it was still necessary to rule out the possibility that the CT-domain of heEF1β may be 
involved in β-γ interaction. The results show that the interaction indeed occurs at the NT-
domains of both proteins, which is a further proof that both proteins are active.  
 
Previous studies have shown that β and δ forms stable complex with γ subunit, and these 
complexes (βγ and δγ) stimulate nucleotide exchange activity by the α-subunit (van Damme et 
al., 1992). The β and δ-subunits share over 81% sequence similarity from the acid-rich region 
downstream (van Damme et al., 1990) . Thus, the α-subunit is able to form transient interaction 
with β and δ-subunits, which enhances nucleotide exchange activity. If the δ and β subunits 
forms stable complex with the γ subunit (Sheu and Traugh, 1997), it means that the only possible 
interacting region is the acid rich cluster, which is common in both subunits. Furthermore, steric 
hindrance will not permit the formation of γβα of γδα complexes because of the proximity 
between the acid rich region and the C-terminus α-binding domain (in β and δ subunits). From 
the results so far, there may be one binding site per protein per β and γ subunit as suggested by 
(Sheu and Traugh, 1997). There was no high order oligomer when NT-heEF1γ interacted with 
FL-heEF1β, and the conformations γ:ββ:γ and γγ:ββ:γγ may be probable. The expected 
molecular weights of the complex will not always correspond to the observed molecular weights 
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because of the orientations of the complex and how it affects the hydrodynamic volumes. There 
is a possibility of the formation of high order complex with γγ:ββ:γγ conformation 
([…γγ:ββ:γγ:ββ:γγ:ββ:γγ:ββ:γγ…]n) if one binding site per molecule is probable. But the absence 
of higher molecular weight complex indicates that there is a possibility that the interaction is 
controlled to prevent the formation of higher molecular complexes when the β and the γ subunits 
interact. In the absence of the CT-domains in the β-subunit, there was a formation of high order 
molecular complex (>670 kDa) when NT-heEF1β interacts with heEF1γ as seen in Figure 3.22. 
The actual molecular basis of this high order complex formation in the absence of residues 140-
225 in NT-heEF1β could not be ascertained at this point in time. However, based on the 
experimental conditions used in this study, the CT-domain may be a role player in the interaction 
between the β and the γ-subunits of EF1 complex. 
The heEF1β protein was characterised with respect to its structure and interaction with heEF1γ 
by dissecting heEF1β into the NT-domain and the α-binding catalytic CT-domain. There is an 
unordered region in central region of the protein that contains a cluster of acidic amino acids 
residues.  
 
4.2 Conclusion and prospective study 
The heEF1β was biophysically characterised with regards to its secondary, tertiary, quaternary 
and protein-protein interaction with the N-terminus GST-like domain of heEF1γ. This study 
reveals that heEF1β is predominantly α-helical with an ANS-accessible hydrophobic cavity on 
the CT- α-subunit binding domain of the protein. This suggests that the interaction between 
heEF1β and heEF1γ may be driven by electrostatic forces that could be contributed by the cluster 
of acidic amino acid residues in the central region of the polypeptide chain. The heEF1β protein 
exists predominantly as a dimer of approximately 62 kDa and the NT-domain of heEF1β is 
responsible for the dimerisation of the protein. The NT-heEF1β interacts with the NT-domain of 
heEF1γ in a possible 1:2 ratio (dimeric β: monomeric γ or dimeric β: dimeric γ) without 
formation of high order molecular complexes. The absence of residue 140-225 in heEF1β 
resulted in high ordered complex with NT-heEF1γ, suggesting that the CT-domain of heEF1β 
may be the modulator for the formation of highly ordered β:γ complex. This study could serve as 
an informative reference for understanding the molecular basis of protein-protein interaction 
between the β and γ-subunits of eEF1 complex in eukaryotes. The β-γ complex is very essential 
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in the nucleotide exchange activity of eEF1 and could be used extensively for commercial 
purpose in the mass production of proteins. The β-γ complex has been seen to increase in certain 
tumour cells and hence could be manipulated for pharmaceutical purposes or drug targets in 
order to understand their influence on tumour cells in cancer research studies. Further research 
such as quantitative study of the interaction between the β and γ subunits of the eEF1 using 
surface plasmon resonance (SPR) and phosphorylation studies of the β and γ subunits of eEF1 
and its effects on their interaction, could improve our knowledge on this PPI.  
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